Extract
Depomed, Inc. Begins Phase III Trial for Metformin GR.
Business Editors/Health & Medical Writers
MENLO PARK, Calif.--(BW HealthWire)--June 21, 2001 DepoMed, Inc. (AMEX:DMI) today announced the opening of the investigator...See the full content of this document
Sponsored links
